nVerses Capital’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-500
Closed -$14.7K 795
2024
Q3
$14.7K Buy
+500
New +$14.7K 0.01% 845